98%
921
2 minutes
20
Background: Lupus enteritis (LE) is the most common serious gastrointestinal manifestation of SLE. Indian literature on LE is limited, while most of the data comes from China and Western series with recent efforts on developing prediction models for its occurrence & recurrence
Objectives: The objectives of the study were to analyse clinical and laboratory parameters of LE, to compare recurrent versus non-recurrent LE and to identify predictors of its recurrence and mortality.
Method: Patients with LE who were admitted to the Rheumatology ward from 2018-2022 were considered cases. For cases, symptoms, abdominal CT findings, and outcome (recurrence or death) were recorded. Logistic regression was used for the prediction of recurrence and mortality.
Result: Among 48 LE patients, 45 were female. The mean (± SD) age of the first enteritis episode was 27.04± 8.92 years. The most frequent extra-gastrointestinal manifestations were nephritis and arthritis (54% of cases). Mean disease duration, lupus nephritis, arthritis, and mean SLEDAI were higher in non-LE patients. Thirteen (27.1%) patients had recurrent LE & hydroureteronephrosis was more prevalent in them (p = 0.002). The logistic regression model using dsDNA complements and albumin failed to predict recurrence. Multiple repetitions of the confusion matrix for the mortality prediction model yielded variable ρ scores, suggesting insignificant accuracy prediction.
Conclusion: Colon and bladder involvement is more frequent in recurrent LE. Anti-dsDNA antibodies, complement, disease activity index, and serum albumin failed to predict recurrence and mortality in our cohort.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12312470 | PMC |
http://dx.doi.org/10.31138/mjr.300924.ioe | DOI Listing |
Rev Med Chil
August 2025
Facultad de Medicina, Universidad Católica del Norte, Coquimbo, Chile.
Systemic lupus erythematosus (SLE) is a chronic multisystem inflammatory disease with a wide spectrum of clinical manifestations. Its association with autoimmune hepatitis is well documented; however, there is limited evidence linking it to hepatic overlap syndromes involving primary sclerosing cholangitis. Although cytopenias are a common hematologic manifestation of SLE, pancytopenia is less frequent and is associated with increased morbidity.
View Article and Find Full Text PDFMediterr J Rheumatol
June 2025
K J Somaiya Hospital, Mumbai, Maharashtra, India.
Systemic Lupus Erythematosus (SLE) is an autoimmune disease with varied organ involvement. Gastrointestinal (GI) involvement in SLE is common, with oral mucosal lesions being the most frequently seen. Acute abdomen as a surgical emergency in SLE patients can have multiple causes.
View Article and Find Full Text PDFMediterr J Rheumatol
June 2025
Clinical Immunology and Rheumatology, Nizam's Institute of Medical Sciences, Hyderabad, India.
Background: Lupus enteritis (LE) is the most common serious gastrointestinal manifestation of SLE. Indian literature on LE is limited, while most of the data comes from China and Western series with recent efforts on developing prediction models for its occurrence & recurrence
Objectives: The objectives of the study were to analyse clinical and laboratory parameters of LE, to compare recurrent versus non-recurrent LE and to identify predictors of its recurrence and mortality.
Method: Patients with LE who were admitted to the Rheumatology ward from 2018-2022 were considered cases.
Mediterr J Rheumatol
June 2025
Rheumatology and Clinical Immunology, Attikon University Hospital, Medical School National and Kapodistrian University of Athens, Greece.
Lupus
September 2025
Department of Clinical Immunology and Rheumatology, Institute of Postgraduate Medical Education and Research, Kolkata, India.
ObjectivesTo investigate the clinical profile and risk factors of Posterior Reversible Encephalopathy Syndrome (PRES) in patients with Systemic Lupus Erythematosus (SLE).MethodsIn this retrospective study, the SLE patients admitted with PRES in the Department of Clinical Immunology and Rheumatology, IPGME&R, Kolkata, India from January 1, 2017 to January 31, 2024, were identified. Fifty-three control participants with neuropsychiatric symptoms as per the 1999 American College of Rheumatology case definition criteria were selected from the departmental SLE cohort.
View Article and Find Full Text PDF